Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-079030
Filing Date
2014-11-10
Accepted
2014-11-10 17:05:20
Documents
18
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-21803_110q.htm 10-Q 1817406
2 EX-10.1 a14-21803_1ex10d1.htm EX-10.1 23604
3 EX-10.4 a14-21803_1ex10d4.htm EX-10.4 516949
4 EX-10.6 a14-21803_1ex10d6.htm EX-10.6 124436
5 EX-31.1 a14-21803_1ex31d1.htm EX-31.1 13820
6 EX-31.2 a14-21803_1ex31d2.htm EX-31.2 13962
7 EX-32.1 a14-21803_1ex32d1.htm EX-32.1 8731
8 EX-99.1 a14-21803_1ex99d1.htm EX-99.1 291388
15 GRAPHIC g218031kq07i001.jpg GRAPHIC 40922
16 GRAPHIC g218031kq07i002.jpg GRAPHIC 3540
17 GRAPHIC g218031kq03i001.jpg GRAPHIC 46012
18 GRAPHIC g218031kq03i002.jpg GRAPHIC 38502
  Complete submission text file 0001104659-14-079030.txt   10222825

Data Files

Seq Description Document Type Size
9 EX-101.INS eprs-20140930.xml EX-101.INS 1229961
10 EX-101.SCH eprs-20140930.xsd EX-101.SCH 62008
11 EX-101.CAL eprs-20140930_cal.xml EX-101.CAL 60090
12 EX-101.LAB eprs-20140930_lab.xml EX-101.LAB 543131
13 EX-101.PRE eprs-20140930_pre.xml EX-101.PRE 447834
14 EX-101.DEF eprs-20140930_def.xml EX-101.DEF 285594
Mailing Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116 617-600-4164
EPIRUS Biopharmaceuticals, Inc. (Filer) CIK: 0001135906 (see all company filings)

EIN.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51171 | Film No.: 141209600
SIC: 2834 Pharmaceutical Preparations